Literature DB >> 23358462

Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study.

Eivind Ness-Jensen1, Anna Lindam, Jesper Lagergren, Kristian Hveem.   

Abstract

OBJECTIVES: High body mass index (BMI) is an established risk factor of gastroesophageal reflux symptoms (GERS). The aim of this study was to clarify if weight loss reduces GERS.
METHODS: The study was part of the Nord-Trøndelag health study (the HUNT study), a prospective population-based cohort study conducted in Nord-Trøndelag County, Norway. All residents of the county from 20 years of age were invited. In 1995-1997 (HUNT 2) and 2006-2009 (HUNT 3), 58,869 and 44,997 individuals, respectively, responded to a questionnaire on heartburn and acid regurgitation. Among these, 29,610 individuals (61% response rate) participated at both times and were included in the present study. The association between weight loss and reduction of GERS was calculated using logistic regression. The analyses were stratified by antireflux medication and the results adjusted for sex, age, cigarette smoking, alcohol consumption, education, and physical exercise.
RESULTS: Weight loss was dose-dependently associated with a reduction of GERS and an increased treatment success with antireflux medication. Among individuals with >3.5 units decrease in BMI, the adjusted odds ratio (OR) of loss of any (minor or severe) GERS was 1.98 (95% confidence interval (CI) 1.45-2.72) when using no or less than weekly antireflux medication, and 3.95 (95% CI 2.03-7.65) when using at least weekly antireflux medication. The corresponding ORs of loss of severe GERS was 0.90 (95% CI 0.32-2.55) and 3.11 (95% CI 1.13-8.58).
CONCLUSIONS: Weight loss was dose-dependently associated with both a reduction of GERS and an increased treatment success with antireflux medication in the general population.

Entities:  

Mesh:

Year:  2013        PMID: 23358462     DOI: 10.1038/ajg.2012.466

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  21 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Risk factors on the development of new-onset gastroesophageal reflux symptoms. A population-based prospective cohort study: the HUNT study.

Authors:  Andreas Hallan; Maria Bomme; Kristian Hveem; Jane Møller-Hansen; Eivind Ness-Jensen
Journal:  Am J Gastroenterol       Date:  2015-02-10       Impact factor: 10.864

3.  Optimal treatment of laryngopharyngeal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Edoardo Savarino; Andrea Nacci; Salvatore Osvaldo Romeo; Massimo Bellini; Vincenzo Savarino; Bruno Fattori; Santino Marchi
Journal:  Ther Adv Chronic Dis       Date:  2013-11       Impact factor: 5.091

Review 4.  Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations.

Authors:  J H-E Kang; J Y Kang
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

Review 5.  Obesity and GERD.

Authors:  Paul Chang; Frank Friedenberg
Journal:  Gastroenterol Clin North Am       Date:  2013-12-27       Impact factor: 3.806

6.  Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

7.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

Review 8.  ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

Authors:  Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2022-01-01       Impact factor: 10.864

Review 9.  Lifestyle Intervention in Gastroesophageal Reflux Disease.

Authors:  Eivind Ness-Jensen; Kristian Hveem; Hashem El-Serag; Jesper Lagergren
Journal:  Clin Gastroenterol Hepatol       Date:  2015-05-06       Impact factor: 11.382

10.  Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?

Authors:  Kristin M Aasarød; Mats P Mosti; Malin T Finstad; Astrid K Stunes; Reidar Fossmark; Unni Syversen
Journal:  Bone Rep       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.